The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 26, 2021
Filed:
Nov. 11, 2019
Applicant:
Aerie Pharmaceuticals, Inc., Bedminster, NJ (US);
Inventors:
Mitchell A. deLong, Chapel Hill, NC (US);
Susan M. Royalty, Davis, CA (US);
Jill Marie Sturdivant, Chapel Hill, NC (US);
Geoffrey Richard Heintzelman, Durham, NC (US);
Assignee:
Aerie Pharmaceuticals, Inc., Bedminster, NJ (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 217/02 (2006.01); C07D 215/38 (2006.01); C07D 217/04 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
C07D 217/02 (2013.01); C07D 215/38 (2013.01); C07D 217/04 (2013.01); C07D 401/12 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01); C07D 417/12 (2013.01);
Abstract
6-Amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided.